Range
16.15 - 16.9
Vol / Avg.
2.9M/4.7M
Div / Yield
-
52 Wk
3.3 - 17.74
Mkt Cap
2.9B
Payout Ratio
-
Open
16.7
P/E
-
EPS
-0.36
Shares
177.7M
Outstanding
177.7M
Total Float
-
Benzinga - Jun 3, 2021, 7:19AM
load more
Sector: Health Care.Industry: Biotechnology
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.270-0.360 -0.0900
REV8.890M19.059M10.169M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BCRXBioCryst Pharmaceuticals-0.06%2.9B

BioCryst Pharmaceuticals Frequently Asked Questions

Q

How do I buy BioCryst Pharmaceuticals (BCRX) stock?

A

You can purchase shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BioCryst Pharmaceuticals's (BCRX) competitors?

Q

What is the target price for BioCryst Pharmaceuticals (BCRX) stock?

A

The latest price target for BioCryst Pharmaceuticals (NASDAQ: BCRX) was reported by HC Wainwright & Co. on March 24, 2021. The analyst firm set a price target for 19.00 expecting BCRX to rise to within 12 months (a possible 16.71% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BioCryst Pharmaceuticals (BCRX)?

A

The stock price for BioCryst Pharmaceuticals (NASDAQ: BCRX) is $16.28 last updated Today at 8:00:02 PM.

Q

Does BioCryst Pharmaceuticals (BCRX) pay a dividend?

A

There are no upcoming dividends for BioCryst Pharmaceuticals.

Q

When is BioCryst Pharmaceuticals (NASDAQ:BCRX) reporting earnings?

A
BioCryst Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is BioCryst Pharmaceuticals (BCRX) going to split?

A

There is no upcoming split for BioCryst Pharmaceuticals.

Q

What sector and industry does BioCryst Pharmaceuticals (BCRX) operate in?

A

BioCryst Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.